Australasian Leukaemia and Lymphoma Group
18
4
6
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
5.6%
1 terminated/withdrawn out of 18 trials
90.0%
+3.5% vs industry average
33%
6 trials in Phase 3/4
11%
1 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (18)
A Randomised Phase 3 Study Comparing a New Drug (Surovatamig) With Standard Radiotherapy With or Without Rituximab in Adults With Limited Stage Nodal Follicular Lymphoma
Role: lead
ALLG AMLM26 INTERCEPT (Investigating Novel Therapy to Target Early Relapse and Clonal Evolution as Pre-emptive Therapy in AML): A Multi-arm, Precision-based, Recursive, Platform Trial
Role: collaborator
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Role: collaborator
Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy
Role: collaborator
Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma
Role: collaborator
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma
Role: collaborator
Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP
Role: lead
Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Leukaemia
Role: lead
Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL
Role: lead
A Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With Prior BTK Inhibitor Exposure.
Role: lead
Radiotherapy Versus Radiotherapy Plus Chemotherapy in Early Stage Follicular Lymphoma
Role: collaborator
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
Role: collaborator
Reduced Intensity Conditioning Transplantation Versus Standard of Care in Acute Myeloid Leukemia
Role: collaborator
Involved Field Radiotherapy for Non-gastric Marginal Zone Lymphoma
Role: collaborator
Primary Rituximab and Maintenance
Role: collaborator
Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma
Role: collaborator
Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma
Role: collaborator
Chemotherapy and Radiotherapy for Osteolymphoma
Role: collaborator
All 18 trials loaded